Anthracycline extravasation: a comprehensive review of experimental and clinical treatments

Research output: Contribution to journalReviewResearchpeer-review

An accidental extravasation of anthracycline-containing chemotherapy is a feared complication that may lead to necrosis and severe tissue destruction. For four decades, much effort has been done to prevent and treat this devastating condition. Savene has recently been proved to be very effective, and is the only approved treatment against anthracyline extravasation. It is thus now widely recommended. The present article represents a comprehensive review of, and historical insight to, the experimental and clinical studies of surgical and non-surgical treatments of extravasation during forty years of clinical anthracycline treatment.

Original languageEnglish
JournalTumori
Volume95
Issue number3
Pages (from-to)273-82
Number of pages10
ISSN0300-8916
Publication statusPublished - 20 Aug 2009

    Research areas

  • Adrenal Cortex Hormones/therapeutic use, Animals, Anthracyclines/administration & dosage, Antibiotics, Antineoplastic/administration & dosage, Bicarbonates/therapeutic use, Dimethyl Sulfoxide/therapeutic use, Extravasation of Diagnostic and Therapeutic Materials/drug therapy, Fibroblast Growth Factor 2/therapeutic use, Granulocyte Colony-Stimulating Factor/therapeutic use, Granulocyte-Macrophage Colony-Stimulating Factor/therapeutic use, Humans, Hyaluronoglucosaminidase/therapeutic use, Necrosis/chemically induced, Razoxane/therapeutic use, Skin Diseases/chemically induced, Ulcer/chemically induced, alpha-Tocopherol/therapeutic use

ID: 247891329